Revenue
-
Net Income
-$22.4M
▼ 35.6% YoY
EPS
$-4.44
▲ 59.1% YoY
Cash
$11.0M
▼ 10.3% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Silva Raul R. EVP and CSO | Grant | Mar 9, 2026 | 4.5K | $0.00 | $0 | Form 4 ↗ |
Silva Raul R. EVP and CSO | Sell tax | Mar 9, 2026 | 1.8K | $0.00 | $0 | Form 4 ↗ |
Schaffer Shane J. Chief Executive Officer | Grant | Mar 9, 2026 | 6.9K | $0.00 | $0 | Form 4 ↗ |
Schaffer Shane J. Chief Executive Officer | Sell tax | Mar 9, 2026 | 3.0K | $0.00 | $0 | Form 4 ↗ |
Callahan Jennifer L. EVP and CFO | Grant | Mar 9, 2026 | 15.3K | $0.00 | $0 | Form 4 ↗ |
Callahan Jennifer L. EVP and CFO | Sell tax | Mar 9, 2026 | 6.4K | $0.00 | $0 | Form 4 ↗ |
Patel Nilay Dahyabhai EVP, CLO and CCO | Grant | Mar 9, 2026 | 5.5K | $0.00 | $0 | Form 4 ↗ |
Patel Nilay Dahyabhai EVP, CLO and CCO | Sell tax | Mar 9, 2026 | 2.1K | $0.00 | $0 | Form 4 ↗ |
Brams Matthew EVP and Chief Medical Officer | Grant | Mar 9, 2026 | 4.5K | $0.00 | $0 | Form 4 ↗ |
Brams Matthew EVP and Chief Medical Officer | Sell tax | Mar 9, 2026 | 1.0K | $0.00 | $0 | Form 4 ↗ |
Werth Peter J. | Buy | Feb 6, 2026 | 19.5K | $5.04 | $98K | Form 4 ↗ |
Callahan Jennifer L. SVP and CFO | Buy | Feb 6, 2026 | 4.9K | $5.04 | $25K | Form 4 ↗ |
Schaffer Shane J. Chief Executive Officer | Buy | Feb 6, 2026 | 6.8K | $5.04 | $34K | Form 4 ↗ |
Brams Matthew EVP and Chief Medical Officer | Buy | Feb 6, 2026 | 1.9K | $5.04 | $10K | Form 4 ↗ |